Xolair 150 MG/1.2 ML powder VLS
Ended Awarded
- Contract number
- SPE2DB25FD7T6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,044
Award facts
- Contract value 100% obligated
- $40,044.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp has been awarded a $40,044 firm fixed-price delivery order by the Defense Logistics Agency (DLA) for 150 mg/1.2 mL powder vials of Xolair, a prescription biologic medication used primarily to treat moderate to severe allergic asthma and chronic idiopathic urticaria. The contract, awarded on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a non-competitive, competitively awarded delivery order with performance to be completed in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies supporting military healthcare programs globally.
As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp maintains extensive federal contract relationships across the Defense Logistics Agency's Medical Supply Chain, delivering a comprehensive portfolio of medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm fixed-price delivery order structure with short performance windows reflects the DLA's operational approach to pharmaceutical procurement through established prime vendor vehicles, ensuring rapid fulfillment of military medical supply requirements while leveraging competitive indefinite delivery contracts for cost-effective healthcare logistics support.
Quick answers
Who was awarded contract SPE2DB25FD7T6?
SPE2DB25FD7T6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FD7T6 worth?
The government has obligated $40,044 on SPE2DB25FD7T6.
Is contract SPE2DB25FD7T6 an order under another contract?
Yes. SPE2DB25FD7T6 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FD7T6 competed?
The extent of competition for SPE2DB25FD7T6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award